Sukrut Somani Selected Research

poly(propyleneimine)

1/2022	Lactoferrin- and Dendrimer-Bearing Gold Nanocages for Stimulus-Free DNA Delivery to Prostate Cancer Cells.
2/2021	Octadecyl chain-bearing PEGylated poly(propyleneimine)-based dendrimersomes: physicochemical studies, redox-responsiveness, DNA condensation, cytotoxicity and gene delivery to cancer cells.
11/2019	Camptothecin-based dendrimersomes for gene delivery and redox-responsive drug delivery to cancer cells.
12/2018	Redox-sensitive, cholesterol-bearing PEGylated poly(propylene imine)-based dendrimersomes for drug and gene delivery to cancer cells.
11/2018	Regression of prostate tumors after intravenous administration of lactoferrin-bearing polypropylenimine dendriplexes encoding TNF-α, TRAIL, and interleukin-12.
1/2018	PEGylation of polypropylenimine dendrimers: effects on cytotoxicity, DNA condensation, gene delivery and expression in cancer cells.
8/2015	Tumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sukrut Somani Research Topics

Disease

19	Neoplasms (Cancer) 02/2022 - 05/2013
8	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2018
5	Melanoma (Melanoma, Malignant) 02/2022 - 01/2017
2	Brain Diseases (Brain Disorder) 11/2015 - 08/2014
1	Aneuploidy (Aneuploid) 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Brain Neoplasms (Brain Tumor) 11/2015

Drug/Important Bio-Agent (IBA)

9	Dendrimers (Dendrons)IBA 01/2022 - 10/2014
9	Pharmaceutical PreparationsIBA 02/2021 - 05/2013
7	poly(propyleneimine)IBA 01/2022 - 08/2015
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 11/2015
7	Transferrin (beta 2 Transferrin)IBA 01/2021 - 05/2013
4	LactoferrinIBA 01/2022 - 08/2015
3	Nucleic AcidsIBA 02/2021 - 10/2014
3	plumbaginIBA 01/2021 - 06/2019
2	ZeinIBA 02/2022 - 01/2022
2	GoldIBA 01/2022 - 01/2021
2	LigandsIBA 01/2022 - 01/2021
2	NaphthoquinonesIBA 01/2021 - 01/2020
2	Therapeutic UsesIBA 01/2021 - 01/2020
1	Protein CoronaIBA 02/2022
1	MicellesIBA 02/2022
1	LipidsIBA 01/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2021
1	PolyethyleneimineIBA 01/2021
1	PolymersIBA 01/2021
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2020
1	Docetaxel (Taxotere)FDA Link 01/2020
1	Mebendazole (Anti-Worm)FDA Link 01/2020
1	ProdrugsIBA 11/2019
1	Glutathione (Reduced Glutathione)IBA 11/2019
1	CamptothecinIBA 11/2019
1	LuciferasesIBA 09/2019
1	Small Interfering RNA (siRNA)IBA 09/2019
1	Liposomes (Liposome)IBA 06/2019
1	SolutionsIBA 06/2019
1	CholesterolIBA 12/2018
1	Interleukin-12 (IL 12)IBA 11/2018
1	TocotrienolsIBA 01/2017
1	Vitamin E FDA LinkGeneric 01/2017
1	lactoferricin BIBA 08/2015
1	Proteins (Proteins, Gene)FDA Link 05/2013
1	Transferrin Receptors (Transferrin Receptor)IBA 05/2013

Therapy/Procedure

12	Therapeutics 02/2022 - 10/2014
10	Intravenous Administration 01/2021 - 08/2014
1	Intravenous Injections 01/2021
1	Photothermal Therapy 01/2021
1	Drug Therapy (Chemotherapy) 01/2020